Core Viewpoint - The article highlights the insufficient public awareness of scientific smoking cessation methods, particularly regarding cessation medications, despite the existence of effective options and guidelines from WHO [1][12]. Group 1: Smoking Cessation Medications - WHO's first clinical treatment guideline for adult smoking cessation identifies three main types of medications: varenicline, nicotine replacement therapy (NRT), and bupropion [1][12]. - Varenicline is a first-line medication with four domestic companies having approved generic versions, yet sales were below 100 million yuan last year [1][12]. - The sales of varenicline in China have not met expectations, with Pfizer's original product experiencing a significant decline due to safety concerns [1][18]. Group 2: Challenges in Smoking Cessation - Nearly 60% of smokers abandon cessation attempts due to withdrawal symptoms, with a success rate of less than 5% for those relying solely on willpower [7][8]. - The understanding of cessation medications among both smokers and healthcare professionals remains limited, contributing to low utilization rates [13][17]. - The lack of awareness and the absence of these medications in insurance coverage are identified as major barriers to effective smoking cessation [20]. Group 3: Market Trends and Opportunities - The retail market for varenicline is projected to grow significantly, with sales expected to reach 48 million yuan in 2024, reflecting a growth rate exceeding 2000% [20][21]. - Online platforms like JD Health report a more than twofold increase in sales of smoking cessation medications, indicating a shift towards digital health solutions [20]. - The market share of companies like Qianyuan Pharmaceutical in the retail sector is notably high, suggesting potential for further expansion in the smoking cessation market [20][21].

"近年来我国吸烟者尝试戒烟的比例逐渐上升，但是成功率不足10%。"贺青华指出，这一数据的背后折 射出要科学戒烟，配合专业指导，才能提高戒烟的成功率。但遗憾的是，许多人没有掌握科学戒烟的方 法，戒烟药物使用率不足5%。 "希望广大消费者能够充分认识到科学戒烟的重要性，主动选择正规渠道购买戒烟药物，借助专业的力 量，早日摆脱烟瘾的困扰。"贺青华说道。 "仅凭意志力戒烟很难抗衡烟草依赖综合征，这是一种高度成瘾性疾病。"首都医科大学附属北京朝阳医 院烟草依赖治疗研究室主任梁立荣教授指出，尼古丁的成瘾性导致烟民在生理和心理上产生高度依赖， 戒烟需要专业帮助，仅仅建议是不够的。医学研究显示，在戒烟药物联合专业心理和行为方式的帮助 下，可以大幅提升戒烟成功率。 新京报记者 王卡拉 5月31日是世界无烟日。5月30日，在京东健康第一届戒烟行业论坛上发布的《2025控烟戒烟白皮书》 （以下简称"《白皮书》"）显示，受访的吸烟人群中，73.1%的人群吸香烟，26.9%吸电子香烟；有 85.8%的人群每天吸烟高达11-20支，相当于每天要抽一盒烟；吸烟男性约为女性的6倍，36岁-45岁为吸 烟人群第一梯队，约占40.5%；工作群体 ...